GlassScriptPhysician profile
Paul N Kaufman
NPI 1215908074
$800.33
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $538 · 2020: $104 · 2021: $142 · 2022: $16.32.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $287.23 | 2019-2021 | |
| Janssen Biotech, INC. | $115.09 | 2019 | |
| Ferring Pharmaceuticals INC. | $111.58 | 2019 | |
| Coloplast Corp | $52.94 | 2019-2021 | |
| Neotract INC. | $32.80 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.41 | 2019 | |
| Endo Pharmaceuticals INC. | $25.22 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $23.74 | 2019 | |
| Dendreon Pharmaceuticals LLC | $22.86 | 2019 | |
| Boston Scientific Corporation | $16.32 | 2022 | |
| Pfizer INC. | $15.75 | 2019 | |
| Alexion Pharmaceuticals, INC. | $15.55 | 2019 | |
| Amgen INC. | $14.47 | 2019 | |
| Blue Earth Diagnostics | $14.05 | 2019 | |
| Urogen Pharma, INC. | $12.69 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $12.63 | 2019 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$1,195.77 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.